Search
Citius Pharmaceuticals Inc
CTXRAdd to Watchlist
0.575USD
-0.034-5.63%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
12.86MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02No earnings forecast score is currently available for Citius Pharmaceuticals Inc. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 5.00, with a high of 6.00 and a low of 4.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Citius Pharmaceuticals Inc's expected revenue for the next quarter?
Citius Pharmaceuticals Inc's expected revenue is 14.81M.
What is Citius Pharmaceuticals Inc's price target?
Analysts forecast that Citius Pharmaceuticals Inc's price target is USD 5.00, with the highest forecast at USD 6.00 and the lowest forecast at USD 4.00.
How have Citius Pharmaceuticals IncCTXR's recent earnings per share performed?
The market expectation was USD -0.95, while Citius Pharmaceuticals IncCTXR's earnings per share (EPS) for the previous quarter was USD -0.38. EPS for the next quarter is expected at USD -0.01.